☰

Dharmeshkumar Patel

Affiliations: 
Emory University School of Medicine, Atlanta, GA, United States 
Area:
Molecular modeling, Computational Chemistry, Drug-Design
Google:
"Dharmeshkumar Patel"
Tree Publications Similar researchers PubMed Report error

Parents

Sign in to add mentor
Serdar Kuyucak grad student 2013-2017 University of Sydney, Australia
F Marty Ytreberg post-doc 2018-2020 University of Idaho (Physics Tree)
Raymond Schinazi research scientist 2020- Emory University School of Medicine

Children

Sign in to add trainee
Nicholas J Wong research assistant Emory University School of Medicine

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Hurwitz SJ, De R, LeCher JC, et al. (2024) Why Certain Repurposed Drugs Are Unlikely to Be Effective Antivirals to Treat SARS-CoV-2 Infections. Viruses. 16
Fan Z, Pavlova A, Jenkins MC, et al. (2024) Biophysics-Guided Lead Discovery of HBV Capsid Assembly Modifiers. Acs Infectious Diseases. 10: 1162-1173
Amblard F, LeCher JC, De R, et al. (2024) Synthesis and biological evaluation of novel peptidomimetic inhibitors of the coronavirus 3C-like protease. European Journal of Medicinal Chemistry. 268: 116263
Amblard F, Chen Z, Wiseman J, et al. (2023) Synthesis and evaluation of highly potent HBV capsid assembly modulators (CAMs). Bioorganic Chemistry. 141: 106923
Bassit L, Amblard F, Patel DJ, et al. (2023) The Premise of Capsid Assembly Modulators Towards Eliminating HBV Persistence. Expert Opinion On Drug Discovery
LeCher JC, Zandi K, Costa VV, et al. (2022) Discovery of a 2'-Fluoro,2'-Bromouridine Phosphoramidate Prodrug Exhibiting Anti-Yellow Fever Virus Activity in Culture and in Mice. Microorganisms. 10
Patel D, Ono SK, Bassit L, et al. (2022) Assessment of a Computational Approach to Predict Drug Resistance Mutations for HIV, HBV and SARS-CoV-2. Molecules (Basel, Switzerland). 27
Amblard F, Patel D, Michailidis E, et al. (2022) HIV nucleoside reverse transcriptase inhibitors. European Journal of Medicinal Chemistry. 240: 114554
Schinazi RF, Patel D, Ehteshami M. (2022) The best backbone for HIV prevention, treatment, and elimination: Emtricitabine+tenofovir. Antiviral Therapy. 27: 13596535211067599
Patel D, Cox BD, Kasthuri M, et al. (2022) In silico design of a novel nucleotide antiviral agent by free energy perturbation. Chemical Biology & Drug Design
See more...